Current status and advances of immunotherapy in nasopharyngeal carcinoma

Por Jian-Ying Xu, Xiao-Li Wei, Yi-Qin Wang, Feng-Hua Wang
Publicado em 2022-05-01

p.P476S mutation of RBPJL inhibits the efficacy of anti‐PD‐1 therapy in oesophageal squamous cell carcinoma by blunting T‐cell responses

Por Lei Miao, Xiao‐Li Wei, Qi Zhao, JingJing Qi, Chao Ren, Qi‐Nian Wu, Da‐Liang Wei, Jia Liu, Feng‐Hua Wang, Rui‐Hua Xu
Publicado em 2020-01-01

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature

Por Jian-Ying Xu, Wen-Long Guan, Shi-Xun Lu, Xiao-Li Wei, Wen-Jie Shi, Chao Ren, Yu-Hong Li, Sheng-Ping Li, Miao-Zhen Qiu, Feng-Hua Wang
Publicado em 2022-04-01

Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology

Por Liang Zeng, Shu-Hua Li, Shuo-Yu Xu, Shuo-Yu Xu, Kai Chen, Liang-Jun Qin, Xiao-Yun Liu, Fang Wang, Sha Fu, Ling Deng, Feng-Hua Wang, Lei Miao, Le Li, Na Liu, Ran Wang, Hai-Yun Wang, Hai-Yun Wang
Publicado em 2022-05-01

Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases

Por Yun Wang, Yun-Fei Yuan, Hao-Cheng Lin, Bin-Kui Li, Feng-Hua Wang, Zhi-Qiang Wang, Pei-Rong Ding, Gong Chen, Xiao-Jun Wu, Zhen-Hai Lu, Zhi-Zhong Pan, De-Sen Wan, Peng Sun, Shu-Mei Yan, Rui-Hua Xu, Yu-Hong Li
Publicado em 2017-10-01